Form 8-K - Current report:
SEC Accession No. 0001193125-22-299428
Filing Date
2022-12-06
Accepted
2022-12-06 16:28:56
Documents
14
Period of Report
2022-12-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d422123d8k.htm   iXBRL 8-K 37689
2 EX-10.1 d422123dex101.htm EX-10.1 131543
3 EX-99.1 d422123dex991.htm EX-99.1 14341
  Complete submission text file 0001193125-22-299428.txt   358301

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ivvd-20221206.xsd EX-101.SCH 2838
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ivvd-20221206_lab.xml EX-101.LAB 18737
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ivvd-20221206_pre.xml EX-101.PRE 11699
8 EXTRACTED XBRL INSTANCE DOCUMENT d422123d8k_htm.xml XML 3457
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

IRS No.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 221448106
SIC: 2836 Biological Products, (No Diagnostic Substances)